BMS-1 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
产品货号 | 产品名称 | CAS号 | 包装 | 市场价(人民币) | 库存状态 | ||||||||
MPI0923 | BMS-1 |
|
|||||||||||
经销商:您可以直接联系本地区的授权代理商
Email:sales@mesgenbio.com
|
产品概述 | |
---|---|
分子式 :C29H33NO5
分子量 :475.58 纯度 : 99.61%
产品简介:BMS-1 是 PD-1/PD-L1 蛋白质/蛋白质相互作用的抑制剂,IC50 为 6 到 100 nM。
溶解性:DMSO 95 mg/mL (199.75 mM);Water 95 mg/mL (199.75 mM);Ethanol 95 mg/mL (199.75 mM) Description
BMS-1 is an inhibitor of the PD-1/PD-L1 protein/protein interaction (IC50 between 6 and 100 nM).
In Vitro
Since PD-1 mediated the exhaustion of natural killer (NK) cell by binding to its ligand PD-L1, BMS-1 (PD-1/PD-L1 inhibitor 1) (1 μM, 3 days) is used to disturb the interaction between PD-1 and PD-L1. Dexamethasone induced increase of PD-1 expression and decrease of cytotoxicity of the co-cultured NK92 cells are reversed by BMS-1. BMS-1, a small-molecule immune checkpoint inhibitor of PD-1/PD-L1, can be used as a therapeutic strategy for tumor immunotherapy.
In Vivo
BMS-1 (500 μg/mL; 100 μL; i.p.) significantly slows down tumor growth and prolongs the survival rates in BALB/c mice.
Animal Model : BALB/c mice
Dosage : 500 μg/mL; 100 μL
Administration : I.p.
Result : Administration significantly slowed down tumor growth and prolonged the survival rates.
Storage condition
-20°C
For Research Use Only. Not For Use In Diagnostic Procedures.
|
产品手册 | MSDS | COA | 参考 |
---|---|---|---|